Avalon to Release Third Quarter 2005 Financial Results on November 8, 2005
November 02 2005 - 11:44AM
PR Newswire (US)
GERMANTOWN, Md., Nov. 2 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (NASDAQ:AVRX) (ArcaEx(R)) today announced
that it is scheduled to release financial results for the third
quarter of 2005, on Tuesday, November 8, 2005 after the close of
the U.S. financial markets. The Company will host a conference call
on November 9th at 8:00 a.m. Eastern Time to provide a company
update and discuss the financial results for the quarter.
Interested investors, analysts, members of the media and the
general public can listen to the call live over the Internet from
the investor section of the Company's website or by dialing the
numbers listed below. Conference Call Details: Dial-In: (866)
510-0676 (U.S.) (617) 597-5361 (International) Passcode: Avalon
Pharmaceuticals Webcast: Please go to http://www.avalonrx.com/,
Investors, within 15 minutes prior to the call and select the
webcast link. The conference call replay will be available through
January 31, 2006 on Avalon's website (http://www.avalonrx.com/).
About Avalon Pharmaceuticals Avalon Pharmaceuticals is a
biopharmaceutical company focused on the discovery and development
of small molecule therapeutics for the treatment of cancer. Avalon
seeks to discover and develop novel therapeutics through the use of
a comprehensive, innovative and proprietary suite of technologies
based upon large-scale gene expression analysis which it calls
AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is
headquartered in Germantown, Maryland. DATASOURCE: Avalon
Pharmaceuticals CONTACT: Gary Lessing, Chief Financial Officer of
Avalon Pharmaceuticals, Tel: +1-301-556-9828, Fax: +1-301-556-9910,
or Web site: http://www.avalonrx.com/
Copyright
Avalon (NASDAQ:AVRX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Avalon (NASDAQ:AVRX)
Historical Stock Chart
From Aug 2023 to Aug 2024